Publications

Detailed Information

DNA methyltransferase 3B mutant in ICF syndrome interacts non-covalently with SUMO-1

Cited 9 time in Web of Science Cited 10 time in Scopus
Authors

Park, Jinah; Kim, Tae-You; Jung, Yeonjoo; Song, Sang-Hyun; Kim, Sung-Hak; Oh, Do-Youn; Im, Seock-AhBang, Yung-Jue

Issue Date
2008-11
Publisher
Springer Verlag
Citation
Journal of Molecular Medicine, Vol.86 No.11, pp.1269-1277
Abstract
Mutations of the DNA methyltransferase 3B (DNMT3B) gene have been detected in patients with immunodeficiency, centromere instability, and facial anomalies (ICF) syndrome. Most of these mutations are clustered in its catalytic domain and thus lead to defective DNA methylation. Nevertheless, the S270P mutation in the N-terminal PWWP (Pro-Trp-Trp-Pro) domain of the DNMT3B gene has prompted questions as to how this mutation contributes to the development of ICF syndrome. In this study, we found that wild-type DNMT3B is SUMOylated through covalent modification, whereas the S270P mutant interacts with SUMO-1 via non-covalent interaction. The S270P mutation results in diffuse nucleus localization. Moreover, the S270P mutant fails to interact with PIAS1, a small ubiquitin-related modifier (SUMO) E3 ligase, and causes the constitutive activation of nuclear factor-kappa B, which induces the expression of interleukin 8. Collectively, our data demonstrate that the S270P mutation affects DNMT3B functions via specific, non-covalent interaction with SUMO-1.
ISSN
0946-2716
Language
English
URI
https://hdl.handle.net/10371/62182
DOI
https://doi.org/10.1007/s00109-008-0392-5
Files in This Item:
There are no files associated with this item.
Appears in Collections:

Related Researcher

  • College of Medicine
  • Department of Medicine
Research Area Clinical Medicine

Altmetrics

Item View & Download Count

  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Share